Recon: FDA schedules June adcomm to review Lilly Alzheimer’s drug; Medtronic cleared to sell renal denervation device in China
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States